SynBioBeta Speaker
Shelby Newsad
Compound
Partner
AI in bio; autonomous science, decentralized science, consumer biology
Sessions Featuring
Shelby
This Year
•
-
Business of Biology
Investor Roundtable Luncheon
Once a year we put the investors in a room by themselves. No startups. No pitches. No slides. Just the people actually moving capital across biotech and synthetic biology, talking honestly about what they're seeing: what's working, what might be overhyped, and where the real opportunities are right now. It's the conversation you can't have when founders are listening. It's invitation-only and space is limited
Featuring
Omri Amirav-Drory
NFX
General Partner
Scientist-founder VC: built Genome Compiler, now backs techbio.
Vatshal Bhanushali
Genoa Ventures
Venture Associate
Kid Parchariyanon
SeaX Ventures
Managing Partner
Physician-turned VC backing exponential deeptech and synbio.
Elena Itskovich
Nest Catalyst
Partner
Scientist-investor building Nest Catalyst for biofounders.
David Welch
Synthesis Capital
CSO & Co-founder
Alt-protein scientist-investor, ex-Good Food Institute tech strategist.
Shelby Newsad
Compound
Partner
Scientist-turned-investor funding bold biotech bets.
•
-
Business of Biology
Investor Roundtable Luncheon
Once a year we put the investors in a room by themselves. No startups. No pitches. No slides. Just the people actually moving capital across biotech and synthetic biology, talking honestly about what they're seeing: what's working, what might be overhyped, and where the real opportunities are right now. It's the conversation you can't have when founders are listening. It's invitation-only and space is limited
Featuring
Omri Amirav-Drory
NFX
General Partner
Scientist-founder VC: built Genome Compiler, now backs techbio.
Vatshal Bhanushali
Genoa Ventures
Venture Associate
Kid Parchariyanon
SeaX Ventures
Managing Partner
Physician-turned VC backing exponential deeptech and synbio.
Elena Itskovich
Nest Catalyst
Partner
Scientist-investor building Nest Catalyst for biofounders.
David Welch
Synthesis Capital
CSO & Co-founder
Alt-protein scientist-investor, ex-Good Food Institute tech strategist.
Shelby Newsad
Compound
Partner
Scientist-turned-investor funding bold biotech bets.
